Few With Postpartum Diabetes Meet Recommended HbA1c Monitoring

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 12, 2026.

via HealthDay

TUESDAY, May 12, 2026 -- Few women with postpartum-onset diabetes meet recommended hemoglobin A1c (HbA1c) monitoring guidelines, according to a study published online April 30 in the BMJ Open Diabetes Research & Care.

Natalie A. Boychuk, from the Columbia University Mailman School of Public Health in New York City, and colleagues conducted a retrospective, population-based cohort study involving 5,590 women who delivered in New York City between 2009 and 2016 and experienced postpartum-onset diabetes to examine the association between social determinants of health and access to HbA1c monitoring.

The researchers found that during the study period, few women received all biannual recommended follow-up tests (13.0 percent). Compared with non-Hispanic White women, non-Hispanic Black women were more likely to receive their first follow-up test later (adjusted hazard ratio, 0.90; 95 percent confidence interval [CI], 0.80 to 1.00) and had a lower rate of testing over three years (adjusted rate ratio, 0.92; 95 percent CI, 0.84 to 0.99). A higher hazard of an earlier first follow-up and higher rates of testing were experienced by women insured by Medicaid at delivery compared with those with private or other insurance (adjusted hazard ratio, 1.14 [95 percent CI, 1.06 to 1.22]; adjusted rate ratio, 1.09 [95 percent CI, 1.03 to 1.15]). Lower rates of testing and a longer time to first HbA1c test were seen for women with more children compared with those with no prior children.

"Our study provides first-of-its-kind evidence on the relationship between social determinants of health and recommended A1C monitoring among postpartum women with newly diagnosed diabetes," Boychuk said in a statement. "Our findings reveal disparities by race and ethnicity, insurance, and parity -- and show that most women are not meeting recommended testing intervals."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-05-13 02:44

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords